Bioavailability of Binimetinib 45 mg Tablet vs 3x15 mg Tablets

Phase 1, randomised, open-label trial of binimetinib in melanoma (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoints: Area under the plasma concentration-time curve from time of administration to last observed plasma concentration, Area under the plasma concentration-time curve from time of administration to infinity and 3 more. Status: unknown.